Screener
Alignment Healthcare ALHC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Alignment Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Alignment Healthcare’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:14 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028901
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash provided by financing activities | 515 | 181 |
| Net increase in cash | 129,775 | 13,335 |
| Cash, cash equivalents and restricted cash at beginning of period | 577,937 | 434,942 |
| Cash, cash equivalents and restricted cash at end of period | $707,712 | $448,277 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | — | — |
| Supplemental non-cash investing and financing activities: | ||
| Acquisition of property in accounts payable | $94 | $85 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Alignment Healthcare's cash & equivalents?
- Alignment Healthcare (ALHC) reported cash & equivalents of $707.71M in Q1 2026.
- How has Alignment Healthcare's cash & equivalents changed year-over-year?
- Alignment Healthcare's cash & equivalents increased by 57.9% year-over-year, from $448.28M to $707.71M.
- What is the long-term trend for Alignment Healthcare's cash & equivalents?
- Over 5 years (2020 to 2025), Alignment Healthcare's cash & equivalents has grown at a 22.8% compound annual growth rate (CAGR), from $207.31M to $577.94M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Alignment Healthcare's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude